← Daily Disruptor / August 3, 2026

Daily Disruptor: $ALM, The Western Tungsten Mine the Market Is Underpricing

Sector research: The chokepoint nobody owns →

What changed

On July 1, 2026, Almonty Industries announced that its Sangdong processing plant in South Korea had started feeding stockpiled ore and producing saleable tungsten concentrate. That is not a project update. That is a business turning on. The company had spent years and hundreds of millions of dollars building the mine, and for most of that time the equity traded as a development story with a big promise attached. The July 1 announcement changes the category. Sangdong is now an operating mine.

Two weeks later, on July 14, Almonty amended its long term offtake agreement with Global Tungsten and Powders, a Plansee Group company headquartered in Pennsylvania. The amendment extended the contract from 15 to 21 years, lifted contracted volumes by 40% to 4.41 million metric tonne units, and improved pricing by roughly 6.3%. At current ammonium paratungstate benchmark prices, the revised agreement represents approximately US$490 million in contracted annual revenue, covering 90% of Phase I output. That is not a letter of intent. It is a 21-year binding commercial agreement, signed after the plant was running.

The company

Almonty Industries mines, processes, and ships tungsten concentrate. It has been doing that for years from the Panasqueira Mine in Portugal, which delivered all of the company’s operating revenue until recently. Sangdong, in Gangwon Province, South Korea, is a different magnitude. It is widely regarded as one of the largest and highest grade undeveloped tungsten deposits in the world, and the reason the company raised $700 million in convertible notes in June 2026 to fund the build. Almonty trades on the Nasdaq under ALM, and it joined the Russell 1000 on June 29, 2026, based on market capitalization measured in late April. The company relocated its corporate headquarters from Toronto to Dillon, Montana in the first quarter, a deliberate signal to US government and defense stakeholders.

The detail most people skip: going into the plant’s commissioning, Almonty had stockpiled approximately 139,700 tonnes of run of mine ore at Sangdong at a blended grade of roughly 0.25% tungsten trioxide. At prevailing prices, that stockpile carries an illustrative gross in process value of about US$68 million. The mine is not waiting for ore. The ore is waiting for the mill.

The numbers

First quarter 2026 revenue came in at $25.4 million, up 221% from $7.9 million in the same period a year earlier. That print came entirely from Panasqueira, which ran hard on record tungsten prices. Adjusted EBITDA flipped from negative $2.4 million in Q1 2025 to positive $6.1 million. Operating cash flow turned positive at $9.7 million. Sangdong had not shipped a single tonne of concentrate when those numbers were filed on May 11, 2026. Q2 2026, the period ending June 30, will include the first partial months of Sangdong ore feeding the mill, and Q3 will be the first full quarter of Sangdong concentrate production.

Nine analysts currently cover ALM with a Strong Buy consensus and an average 12-month price target of $23.71. The $700 million in convertible notes carries a 2.25% coupon, matures in 2031, and has an initial conversion price of approximately $27.40 per share. Almonty entered into capped call transactions to limit dilution above $41.36 per share. Short interest stands at roughly 1.5% of the float, which is low given how much has changed operationally. Annual 2025 revenue was $32.5 million. If Sangdong ramps toward Phase I capacity, the quarterly revenue profile in 2026 and 2027 looks nothing like the historical filings.

Why now

The catalyst is the Q2 2026 earnings print, expected around mid August 2026 based on prior year reporting cadence. That will be the first financial statement to show Sangdong ore entering the plant and concentrate leaving it. The market has been trading ALM for most of 2026 on the expectation of this moment. The stock pulled back sharply in July, roughly 26% from its early June peak, as investors digested the convertible deal, voluntary delistings from the TSX and ASX, and some insider selling. The operational news since then has been consistent and positive. Investors who bought the story before the mine ran are watching the same earnings report as everyone else, which means Q2 could be the first result that forces the crowd to recalibrate.

Positioning is genuinely light. Short interest near 1.5% of float means there is no short squeeze mechanism, but it also means the stock is not heavily defended. Nine analysts is more coverage than most names we feature here, but institutional ownership is still building following the Russell 1000 addition in June. The market appears to believe the July pullback was warranted by dilution risk. We think it underweights what Sangdong looks like at full Phase I throughput against a $490 million annual offtake contract.

What breaks it

The $700 million convertible is the most direct threat to the thesis. The initial conversion price sits at $27.40, and while the capped calls limit dilution above $41.36, potential equity issuance at $27.40 is meaningful relative to where the stock has been trading after the July pullback. If the ramp at Sangdong is slower than projected, whether from lower mill recoveries, grade variability, or logistics delays through the Port of Incheon, the revenue inflection gets pushed out and the carrying cost of the convertible becomes a heavier burden. China controls roughly 80 to 90 percent of global tungsten production, and if Beijing reverses its export restriction policy, the APT price on which that $490 million offtake is calculated falls materially. Tungsten prices at historic highs are a tailwind now. They are also a valuation assumption that carries commodity risk.

Not financial advice.

The setup

ALM closed at 11.06, sitting 32.4% below its 50 day average and 20.2% below its 200 day average, so the trend is against the thesis on both timeframes. The stock is at 37% of its 52 week range and 52.8% off its 52 week high, meaning it has already fallen a long way. The one month return is negative 29.6% and the three month return is negative 46.3%, with relative strength versus the market running negative 50.0 points over the past quarter. Volume over the last ten days is running at 1.07 times the 50 day average, which is roughly normal, offering no unusual accumulation signal either way. The average true range is 11.4% of price, so daily swings are large relative to the share price. RSI at 31 is near oversold territory but that alone says nothing about when or whether a floor arrives.

The historical base rate on this ticker is thin and should carry little weight. Across 18 prior days when ALM sat in a comparable technical position, the median outcome was negative 14.5% over the following month and negative 14.6% over the following quarter. The stock was higher one month later only 17% of the time and higher one quarter later only 11% of the time, with quarterly outcomes ranging from negative 23.0% to positive 20.0%. That spread shows the range of what happened before on this one ticker. It is not a forecast and the future is not obliged to match any of those prior outcomes. With such a small sample the base rate adds texture but no real statistical confidence.

References

  1. Almonty Industries Inc. Form 6-K, Exhibit 99.1. First Quarter 2026 Financial Results. US Securities and Exchange Commission. Published May 11, 2026. Accessed August 3, 2026. https://www.sec.gov/Archives/edgar/data/0001670061/000149315226022338/ex99-1.htm
  2. Almonty Industries Inc. Almonty Commences Processing Operations at Sangdong Mine, Marking Transition to Saleable Tungsten Concentrate Production. Business Wire. Published July 1, 2026. Accessed August 3, 2026. https://finance.yahoo.com/markets/commodities/articles/almonty-commences-processing-sangdong-113000103.html
  3. Almonty Industries Inc. Almonty Expands Sangdong Tungsten Offtake Agreement with Global Tungsten and Powders to US$490 Million in Contracted Annual Revenue at Current APT Pricing. Business Wire. Published July 14, 2026. Accessed August 3, 2026. https://www.businesswire.com/news/home/20260714866567/en/Almonty-Expands-Sangdong-Tungsten-Offtake-Agreement-with-Global-Tungsten-Powders-to-US$490-Million-in-Contracted-Annual-Revenue-at-Current-APT-Pricing
  4. Almonty Industries Inc. Form 6-K. Sangdong Q2 2026 operational update. US Securities and Exchange Commission. Published July 1, 2026. Accessed August 3, 2026. https://www.sec.gov/Archives/edgar/data/0001670061/000149315226031435/ex99-1.htm
  5. Almonty Industries Inc. Almonty Industries Prices Oversubscribed US$700 Million Convertible Senior Notes Offering. Almonty Industries. Published June 5, 2026. Accessed August 3, 2026. https://almonty.com/prices-oversubscribed-us700-million-convertible-senior-notesoffering/
  6. Stock Analysis. Almonty Industries (ALM) Stock Price and Overview. Accessed August 3, 2026. https://stockanalysis.com/stocks/alm/
  7. MarketBeat. Almonty Industries (ALM) Earnings Date, Estimates and Call Transcripts. Accessed August 3, 2026. https://www.marketbeat.com/instant-alerts/almonty-industries-nasdaqalm-announces-quarterly-earnings-results-2025-08-15
  8. TipRanks. Almonty Boosts Sangdong Tungsten Offtake Deal to US$490 Million in Annual Revenue. Published July 14, 2026. Accessed August 3, 2026. https://www.tipranks.com/news/company-announcements/almonty-boosts-sangdong-tungsten-offtake-deal-to-us490-million-in-annual-revenue
  9. StockTitan. Short interest in Almonty Industries (ALM) currently stands at 3.3 million shares, representing 1.5% of the float. Accessed August 3, 2026. https://www.stocktitan.net/overview/ALM/
Positions and business relationships. Assume that Dr. Paul Christianson and/or Disruptor Investing, LLC may hold a long or short position in any security mentioned above, whether or not a position is stated, and may buy or sell at any time without notice. Assume also that a company mentioned above may be a current or former paid client of Disruptor Investing's CEO interview program, or may otherwise have a business relationship with Disruptor Investing, whether or not that relationship is stated above. These relationships are material conflicts of interest and should be weighed against everything stated in this post.

Nothing here is investment, legal, tax, or financial advice, an offer, or a solicitation to buy or sell any security. Dr. Christianson is not a registered financial advisor, investment adviser, or broker-dealer. Educational content only. Investing involves risk of loss, including total loss of principal; micro-cap and small-cap securities carry heightened risk. Full disclosures and compensation terms.